Multiple cycles of repeated treatments with a Phaseolus vulgaris dry extract reduce food intake and body weight in obese rats

British Journal of Nutrition

Volumn 106, Issue 5, 2011, Pages 762-768

  Carai, Mauro A M ^a,b   Fantini, Noemi ^a   Loi, Barbara ^a   Colombo, Giancarlo ^a   Gessa, Gian Luigi ^a   Riva, Antonella ^c   Bombardelli, Ezio ^c   Morazzoni, Paolo ^c  

^a CNR   (Italy)

^b Cagliari Pharmacological Research Srl   (Italy)

^c INDENA S P A   (Italy)

Author keywords

Body weight; Food intake; Glycaemia; Obese Zucker fa fa rats; Phaseolus vulgaris dry extract (Beanblock )

Indexed keywords

ANTIOBESITY AGENT; GLUCOSE; PHASEOLUS VULGARIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FOOD DEPRIVATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; MALE; MULTIPLE CYCLE TREATMENT; NONHUMAN; OBESITY; PHASEOLUS VULGARIS; POSTPRANDIAL STATE; RAT; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; FEEDING BEHAVIOR; PHASEOLUS; PLANT EXTRACTS; RATS; RATS, ZUCKER;

ANIMALIA; PHASEOLUS VULGARIS; RATTUS;

EID: 80052983640     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511000778     Document Type: Article

References (34)

1. Obiro WC, Zhang T & Jiang B (2008) The nutraceutical role of the Phaseolus vulgaris alpha-amylase inhibitor. Br J Nutr 100, 1-12.
2. Pusztai A, Bardocz S & Ewen SWB (2008) Uses of plant lectins in bioscience and biomedicine. Front Biosci 13, 1130-1140. (Pubitemid 351594754)
3. Carai MAM, Fantini N, Loi B, et al. (2009) Potential efficacy of preparations deriving from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism. Diabetes Meta Syn Obes Targ Ther 2, 145-153.
4. Tormo MA, Gil-Exojo I, Romero de Tejada A, et al. (2004) Hypoglycaemic and anorexigenic activities of an a-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats. Br J Nutr 92, 785-790. (Pubitemid 39562157)
5. Tormo MA, Gil-Exojo I, Romero de Tejada A, et al. (2006) White bean amylase inhibitor administered orally reduces glycaemia in type 2 diabetic rats. Br J Nutr 96, 539-544.
6. Fantini N, Cabras C, Lobina C, et al. (2009) Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats. J Agric Food Chem 57, 9316-9323.
7. Maccioni P, Colombo G, Riva A, et al. (2010) Reducing effect of a Phaseolus vulgaris dry extract on operant selfadministration of a chocolate-flavoured beverage in rats. Br J Nutr 104, 624-628.
8. Donatucci DA, Liener IE & Gross CJ (1987) Binding of navy bean (Phaseolus vulgaris) lectin to the intestinal cells of the rat and its effect on the absorption of glucose. J Nutr 117, 2154-2160. (Pubitemid 18030602)
9. Grant G, Dorward PM, Buchan WC, et al. (1995) Consumption of diets containing raw soya beans (Glycine max), kidney beans (Phaseolus vulgaris), cowpeas (Vigna unguiculata) or lupin seeds (Lupinus angustifolius) by rats for up to 700 days: effects on body composition and organ weights. Br J Nutr 73, 17-29.
10. Pusztai A, Grant G, Duguid T, et al. (1995) Inhibition of starch digestion by a-amylase inhibitor reduces the efficiency of utilization of dietary proteins and lipids and retards the growth of rats. J Nutr 125, 1554-1562.
11. Bardocz S, Grant G & Pusztai A (1996) The effect of phytohaemagglutinin at different dietary concentrations on the growth, body composition and plasma insulin of the rat. Br J Nutr 76, 613-626. (Pubitemid 26372283)
12. Pusztai A, Grant G, Buchan WC, et al. (1998) Lipid accumulation in obese Zucker rats is reduced by inclusion of raw kidney bean (Phaseolus vulgaris) in the diet. Br J Nutr 79, 213-221. (Pubitemid 28081872)
13. Zucker LM & Zucker TF (1961) Fatty, a new mutation in the rat. J Hered 52, 275-278.
14. Bray GA (1977) Zucker fatty rat: a review. Fed Proc 36, 148-153.
15. Meierfrankenfeld B, Abelenda M, Jauker H, et al. (1996) Perinatal energy stores and excessive fat deposition in genetically obese ( fa/fa) rats. Am J Physiol 270, E700-E708.
16. Beck B (2000) Neuropeptides and obesity. Nutrition 16, 1916-1923.
17. Moreno J & Chrispeels MJ (1989) A lectin gene encodes the a-amylase inhibitor of the common bean. PNAS 86, 7885-7889.
18. Ishimoto M, Suzuki K, Iwanaga M, et al. (1995) Variation of seed-amylase inhibitors in the common bean. Theor Appl Gen 90, 425-429.
19. Sharma V & Surolia A (1997) Analyses of carbohydrate recognition by legume lectins: size of the combining site loops and their primary specificity. J Mol Biol 267, 433-445. (Pubitemid 27149851)
20. Lee SC, Gepts PL & Whitaker JR (2002) Protein structures of common bean (Phaseolus vulgaris) a-amylase inhibitors. J Agric Food Chem 50, 6618-6627. (Pubitemid 35216782)
21. Santimone M, Koukiekolo R, Moreau Y, et al. (2004) Porcine pancreatic alpha-amylase inhibition by the kidney bean (Phaseolus vulgaris) inhibitor (a-AI1) and structural changes in the a-amylase inhibitor complex. Biochim Biophys Acta 1696, 181-190. (Pubitemid 38199848)
22. Jain NK, Boivin M, Zinsmeister AR, et al. (1989) Effect of ileal perfusion of carbohydrates and amylase inhibitor on gastrointestinal hormones and emptying. Gastroenterology 96, 377-387. (Pubitemid 19045268)
23. Jain NK, Boivin M, Zinsmeister AR, et al. (1991) The ileum and carbohydrate-mediated feedback regulation of postprandial pancreaticobiliary secretion in normal humans. Pancreas 6, 495-505.
24. King TP, Pusztai A, Grant G, et al. (1986) Immunogold localization of ingested kidney bean (Phaseolus vulgaris) lectins in epithelial cells of the rat small intestine. Histochem J 18, 413-420.
25. Bardocz S, Grant G, Ewen SW, et al. (1995) Reversible effect of phytohaemagglutinin on the growth and metabolism of rat gastrointestinal tract. Gut 37, 353-360.
26. Herzig KH, Bardocz S, Grant G, et al. (1997) Red kidney bean lectin is a potent cholecystokinin releasing stimulus in the rat inducing pancreatic growth. Gut 41, 333-338. (Pubitemid 27428192)
27. Ra°dberg K, Biernatt M, Linderoth A, et al. (2001) Enteral exposure to crude red kidney bean lectin induces maturation of the gut in suckling pigs. J Anim Sci 79, 2669-2678. (Pubitemid 33721497)
28. Layer P, Carlson GL & Di Magno EP (1985) Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology 88, 1895-1902. (Pubitemid 15052303)
29. Layer P, Zinsmeister AR & Di Magno EP (1986) Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology 91, 41-48. (Pubitemid 16086652)
30. Boivin M, Zinsmeister AR, Go VL, et al. (1987) Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans. Mayo Clin Proc 62, 249-255. (Pubitemid 17052822)
31. Udani J, Hardy M & Madsen DC (2004) Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev 9, 63-69. (Pubitemid 38364882)
32. Udani J & Singh BB (2007) Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract. Altern Ther Health Med 13, 32-37. (Pubitemid 351299280)
33. Celleno L, Tolaini MV, D'Amore A, et al. (2007) A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci 4, 45-52. (Pubitemid 46168687)
34. Rondanelli M, Orsini F, Opizzi A, et al. (2009) The effect of 2-mo administration of a Phaseolus vulgaris and Cynara scolymus complex on feeling of satiation in healthy, overweight people. Obes Facts 2, Suppl. 2, 234.